Search Results - Welliver, Tim

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    433 A phase 2 study of evorpacept (ALX148) in combination with pembrolizumab and chemotherapy in patients with advanced head and neck squamous cell carcinoma (HNSCC); ASPEN-04

    433 A phase 2 study of evorpacept (ALX148) in combination with pembrolizumab and chemotherapy in patients with advanced head and neck squamous cell carcinoma (HNSCC); ASPEN-04 by Cirauqui, Beatriz, Cohen, Ezra, Keam, Bhumsuk, Machiels, Jean-Pascal, Oosting, Sjoukje, Welliver, Tim, Guan, Shanhong, Jin, Feng, Forgie, Alison, Fanning, Philip, Ruffner, Katherine, Pons, Jaume, Randolph, Sophia, Harrington, Kevin

    Request full text
    Article
    Save to List
    Saved in:
  2. 2
    Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM): Efficacy and Safety with 34-Month Median Follow-up

    Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM): Efficacy and Safety with 34-Month Median Follow-up by Bishop, Michael R, Rosenblatt, Jacalyn, Dhakal, Binod, Raje, Noopur, Cook, Daniella, Gaballa, Mahmoud R., Emmanuel-Alejandro, Estelle, Nissen, Danielle, Banerjee, Kamalika, Chan, Rebecca J, Kostic, Ana, Heery, Christopher R., Welliver, Tim, Avigan, David, Jakubowiak, Andrzej J, Frigault, Matthew

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Phase 2 Registrational Study of Anitocabtagene Autoleucel for the Treatment of Patients with Relapsed and/or Refractory Multiple Myeloma: Preliminary Results from the IMMagine-1 Trial

    Phase 2 Registrational Study of Anitocabtagene Autoleucel for the Treatment of Patients with Relapsed and/or Refractory Multiple Myeloma: Preliminary Results from the IMMagine-1 Tr... by Freeman, Ciara Louise, Dhakal, Binod, Kaur, Gurbakhash, Maziarz, Richard T., Callander, Natalie, Sperling, Adam S., Schinke, Carolina, Jakubowiak, Andrzej J, Biran, Noa, Sborov, Douglas W, Varga, Cindy, Deol, Abhinav, Kanate, Abraham S., Koçoğlu, Mehmet Hakan, Solh, Melhem M., Banerjee, Kamalika, Chan, Rebecca, Nahas, Myrna, Kostic, Ana, Granados, Enrique, Jackson, Carolyn, Heery, Christopher R., Welliver, Tim, Patel, Krina K., Frigault, Matthew

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Could Patients with Multiple Myeloma (MM) Derive Additional Benefit from Their Treatments? Real-World Evidence for Carfilzomib Dosing Intensity on Survival and Treatment Progression

    Could Patients with Multiple Myeloma (MM) Derive Additional Benefit from Their Treatments? Real-World Evidence for Carfilzomib Dosing Intensity on Survival and Treatment Progressio... by Medhekar, Rohan, Hines, Dionne, Panjabi, Sumeet, Welliver, Tim, Wang, Xin, Wade, Rolin L.

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Carfilzomib-Lenalidomide-Dexamethasone Versus Bortezomib-Lenalidomide-Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma: Results from the Prospective, Longitudinal, Observational Commpass Study

    Carfilzomib-Lenalidomide-Dexamethasone Versus Bortezomib-Lenalidomide-Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma: Results from the Prospective, Longitudinal, O... by Landgren, Ola, Siegel, David S, Auclair, Daniel, Chari, Ajai, Boedigheimer, Michael, Welliver, Tim, Mezzi, Khalid, Iskander, Karim, Jakubowiak, Andrzej

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Efficacy and Safety of Carfilzomib-Lenalidomide-Dexamethasone (KRd) in Newly Diagnosed Multiple Myeloma: Pooled Analysis of 4 Single-Arm Studies

    Efficacy and Safety of Carfilzomib-Lenalidomide-Dexamethasone (KRd) in Newly Diagnosed Multiple Myeloma: Pooled Analysis of 4 Single-Arm Studies by Landgren, Ola, Attal, Michel, Kazandjian, Dickran, Roussel, Murielle, Jasielec, Jagoda K., Dytfeld, Dominik, Anderson, Aparna, Kervin, Tara, Iskander, Karim, Mezzi, Khalid, Welliver, Tim, Yusuf, Akeem, Jakubowiak, Andrzej

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Real-world evidence for carfilzomib dosing intensity on overall survival and treatment progression in multiple myeloma patients

    Real-world evidence for carfilzomib dosing intensity on overall survival and treatment progression in multiple myeloma patients by Raje, Noopur, Medhekar, Rohan, Panjabi, Sumeet, Hines, Dionne M, Wang, Xin, Iskander, Karim, Welliver, Tim, Wade, Rolin L, Ailawadhi, Sikander

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: